In light sepsis in humans, an acute inflammatory response inducing the TLR4 pathway and inflammatory cytokine production is beneficial, but in severe sepsis these components are dysregulated, preventing inflammatory cytokine production by the PBMCs (Brunialti et al., 2006). This evidence concerns the gene TLR4 and Sepsis.